List of Ezallor Sprinkle drug patents

Ezallor Sprinkle is owned by Sun Pharm.

Ezallor Sprinkle contains Rosuvastatin Calcium.

Ezallor Sprinkle has a total of 1 drug patent out of which 0 drug patents have expired.

Ezallor Sprinkle was authorised for market use on 18 December, 2018.

Ezallor Sprinkle is available in capsule;oral dosage forms.

The generics of Ezallor Sprinkle are possible to be released after 12 February, 2036.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10413543 SUN PHARM Stable multiparticulate pharmaceutical composition of rosuvastatin
Feb, 2036

(13 years from now)

Drugs and Companies using ROSUVASTATIN CALCIUM ingredient

Market Authorisation Date: 18 December, 2018

Treatment: NA

Dosage: CAPSULE;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in